title: Mixture models for gene expression experiments with two species.
abstract: Cross-species research in drug development is novel and challenging. A bivariate mixture model utilizing information across two species was proposed to solve the fundamental problem of identifying differentially expressed genes in microarray experiments in order to potentially improve the understanding of translation between preclinical and clinical studies for drug development. The proposed approach models the joint distribution of treatment effects estimated from independent linear models. The mixture model posits up to nine components, four of which include groups in which genes are differentially expressed in both species. A comprehensive simulation to evaluate the model performance and one application on a real world data set, a mouse and human type II diabetes experiment, suggest that the proposed model, though highly structured, can handle various configurations of differential gene expression and is practically useful on identifying differentially expressed genes, especially when the magnitude of differential expression due to different treatment intervention is weak. In the mouse and human application, the proposed mixture model was able to eliminate unimportant genes and identify a list of genes that were differentially expressed in both species and could be potential gene targets for drug development.
authors.affiliation: Dr, Su's Statistics & Department of Human Nutrition, Food, and Animal Sciences, University of Hawaii at Manoa, Honolulu, HI 96822, USA. yhsejo@gmail.com.
authors.forename: Yuhua
authors.initials: Y
authors.lastname: Su
authors.forename: Lei
authors.initials: L
authors.lastname: Zhu
authors.forename: Alan
authors.initials: A
authors.lastname: Menius
authors.forename: Jason
authors.initials: J
authors.lastname: Osborne
mesh_terms: D000465:Algorithms; D000818:Animals; D003198:Computer Simulation; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D008957:Models, Genetic; D020411:Oligonucleotide Array Sequence Analysis; D013045:Species Specificity; D059467:Transcriptome
chemical_list: D007004:Hypoglycemic Agents
references.citation: Curr Opin Biotechnol. 1998 Dec;9(6):643-9
references.pmid: 9889142
references.citation: Genome Biol. 2004;5(5):R34
references.pmid: 15128448
references.citation: Nat Genet. 1999 Jan;21(1 Suppl):48-50
references.pmid: 9915501
references.citation: Trends Genet. 2002 Dec;18(12):619-20
references.pmid: 12446146
references.citation: Nat Rev Drug Discov. 2002 May;1(5):335-6
references.pmid: 12120408
references.citation: Genome Res. 2000 Jul;10(7):950-8
references.pmid: 10899144
references.citation: Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):31-6
references.pmid: 11134512
references.citation: Drug Discov Today. 2007 Oct;12(19-20):826-32
references.pmid: 17933683
references.citation: Genomics. 2008 Dec;92(6):414-8
references.pmid: 18786629
references.citation: IEEE Trans Neural Netw. 1996;7(1):16-29
references.pmid: 18255555
references.citation: Neural Comput. 2000 Feb;12(2):407-32
references.pmid: 10636949
references.citation: Nat Rev Drug Discov. 2004 Aug;3(8):711-5
references.pmid: 15286737
references.citation: Genome Biol. 2001;2(4):COMMENT1005
references.pmid: 11305932
references.citation: Bioinformatics. 2006 Jun 1;22(11):1359-66
references.pmid: 16527831
references.citation: Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W305-8
references.pmid: 15215399
references.citation: Nature. 2002 Feb 14;415(6873):741
references.pmid: 11845189
references.citation: Nucleic Acids Res. 2002 Jan 1;30(1):113-5
references.pmid: 11752269
references.citation: BMC Genomics. 2008 Apr 24;9:188
references.pmid: 18435860
references.citation: Stat Appl Genet Mol Biol. 2009;8:Article 2
references.pmid: 19222385